Tramadol Hydrochloride Solution
Product Images NDC 52817-615

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 52817-615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

16oz Bottle (Trupharma Tramadol Hci Bottle)

16oz Bottle (Trupharma Tramadol Hci Bottle)
Label for Tramadol Hydrochloride oral solution 5 mg/mL distributed by TruPharma, LLC. The 16 fl. oz. (473 mL) bottle displays dosing information, storage instructions (20°C to 25°C, excursions permitted), and a warning that the product is for adults only. It includes handling and safety notes such as keeping out of reach of children and not using if the foil seal is broken or missing.*
FDA Label Image

Chemical Structure (Figure 01)

Chemical Structure (Figure 01)
Chemical structure of tramadol hydrochloride showing the molecular arrangement with a methoxy-substituted aromatic ring, cyclohexane ring, hydroxyl group, and an N,N-dimethylamino group, accompanied by a hydrochloride ion (HCl).*
FDA Label Image

Figure 1 (Figure 02)

Figure 1 (Figure 02)
A pharmacokinetic graph depicting the concentration (ng/mL) of tramadol and its metabolite M1 over time (hours). The graph compares multiple dose and single dose profiles of tramadol and M1, showing declining concentrations over a 48-hour period.*
FDA Label Image

Figure 2 (Figure 03)

Figure 2 (Figure 03)
A line graph titled 'Protocol CAPSS-047' showing time to discontinuation due to nausea/vomiting for tramadol hydrochloride. The x-axis represents days in double-blind, and the y-axis shows percent discontinuing. Two lines compare 10 days versus 16 days to 200 mg/day dosage, illustrating higher discontinuation rates for the shorter titration period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.